Opko Health, Inc. - Net Worth and Insider Trading
Opko Health, Inc. Net Worth
The estimated net worth of Opko Health, Inc. is at least $56 Million dollars as of 2024-05-06. Opko Health, Inc. is the 10% Owner of GeneDx Holdings Corp and owns about 2,857,140 shares of GeneDx Holdings Corp (WGS) stock worth over $56 Million. Opko Health, Inc. is the 10% Owner of VBI Vaccines Inc and owns about 222,625 shares of VBI Vaccines Inc (VBIV) stock worth over $131,349. Opko Health, Inc. is also the 10% Owner of Sorrento Therapeutics Inc and owns about 2,173,859 shares of Sorrento Therapeutics Inc (SRNE) stock worth over $32,608. Details can be seen in Opko Health, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Opko Health, Inc. has not made any transactions after 2023-01-26 and currently still holds the listed stock(s).
Transaction Summary of Opko Health, Inc.
Opko Health, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Opko Health, Inc. owns 6 companies in total, including Eloxx Pharmaceuticals Inc (ELOX) , VBI Vaccines Inc (VBIV) , and Cocrystal Pharma Inc (COCP) among others .
Click here to see the complete history of Opko Health, Inc.’s form 4 insider trades.
Insider Ownership Summary of Opko Health, Inc.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ELOX | Eloxx Pharmaceuticals Inc | 2017-07-28 | 10 percent owner |
VBIV | VBI Vaccines Inc | 2017-10-30 | 10 percent owner |
COCP | Cocrystal Pharma Inc | 2014-03-17 | 10 percent owner |
2013-11-22 | 10 percent owner | ||
2013-03-12 | 10 percent owner | ||
2023-01-26 | 10 percent owner |
Opko Health, Inc. Latest Holdings Summary
Opko Health, Inc. currently owns a total of 3 stocks. Among these stocks, Opko Health, Inc. owns 2,857,140 shares of GeneDx Holdings Corp (WGS) as of January 26, 2023, with a value of $56 Million and a weighting of 99.71%. Opko Health, Inc. owns 222,625 shares of VBI Vaccines Inc (VBIV) as of October 30, 2017, with a value of $131,349 and a weighting of 0.23%. Opko Health, Inc. also owns 2,173,859 shares of Sorrento Therapeutics Inc (SRNE) as of November 22, 2013, with a value of $32,608 and a weighting of 0.06%.
Latest Holdings of Opko Health, Inc.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
WGS | GeneDx Holdings Corp | 2023-01-26 | 2,857,140 | 19.66 | 56,171,372 |
VBIV | VBI Vaccines Inc | 2017-10-30 | 222,625 | 0.59 | 131,349 |
SRNE | Sorrento Therapeutics Inc | 2013-11-22 | 2,173,859 | 0.02 | 32,608 |
Holding Weightings of Opko Health, Inc.
Opko Health, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Opko Health, Inc. has made a total of 1 transactions in GeneDx Holdings Corp (WGS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in GeneDx Holdings Corp is the acquisition of 432,900 shares on January 26, 2023, which cost Opko Health, Inc. around $5 Million.
According to the SEC Form 4 filings, Opko Health, Inc. has made a total of 0 transactions in VBI Vaccines Inc (VBIV) over the past 5 years. The most-recent trade in VBI Vaccines Inc is the acquisition of 21,858 shares on October 30, 2017, which cost Opko Health, Inc. around $2 Million.
According to the SEC Form 4 filings, Opko Health, Inc. has made a total of 0 transactions in Sorrento Therapeutics Inc (SRNE) over the past 5 years. The most-recent trade in Sorrento Therapeutics Inc is the sale of 8,471 shares on November 22, 2013, which brought Opko Health, Inc. around $72,004.
Insider Trading History of Opko Health, Inc.
- 1
Opko Health, Inc. Trading Performance
GuruFocus tracks the stock performance after each of Opko Health, Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Opko Health, Inc. is -4.5%. GuruFocus also compares Opko Health, Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Opko Health, Inc. within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Opko Health, Inc.'s insider trading performs compared to the benchmark.
Performance of Opko Health, Inc.
Opko Health, Inc. Ownership Network
Ownership Network List of Opko Health, Inc.
Ownership Network Relation of Opko Health, Inc.
Opko Health, Inc. Owned Company Details
What does Eloxx Pharmaceuticals Inc do?
Who are the key executives at Eloxx Pharmaceuticals Inc?
Opko Health, Inc. is the 10 percent owner of Eloxx Pharmaceuticals Inc. Other key executives at Eloxx Pharmaceuticals Inc include director & PRESIDENT AND CEO Sumit Aggarwal , HEAD OF R&D Vijay Modur , and Chief Financial Officer Daniel E. Geffken .
Eloxx Pharmaceuticals Inc (ELOX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eloxx Pharmaceuticals Inc (ELOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eloxx Pharmaceuticals Inc (ELOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eloxx Pharmaceuticals Inc (ELOX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eloxx Pharmaceuticals Inc Insider Transactions
Opko Health, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Opko Health, Inc.. You might contact Opko Health, Inc. via mailing address: 4400 Biscayne Blvd., Miami Fl 33137.